دورية أكاديمية

Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.

التفاصيل البيبلوغرافية
العنوان: Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.
المؤلفون: Santos BF; Department of Medicine, Federal University of Sergipe, Aracaju, Sergipe 49060-100, Brazil., de Santana NO, Franca AV
المصدر: World journal of gastroenterology [World J Gastroenterol] 2011 Jul 07; Vol. 17 (25), pp. 3027-34.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN: 2219-2840 (Electronic) Linking ISSN: 10079327 NLM ISO Abbreviation: World J Gastroenterol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
Original Publication: Beijing : WJG Press, c1998-
مواضيع طبية MeSH: Genotype* , Prisoners*, Hepacivirus/*genetics , Hepatitis C/*epidemiology, Adult ; Brazil/epidemiology ; Cross-Sectional Studies ; Female ; Hepatitis C/genetics ; Hepatitis C/transmission ; Humans ; Male ; ROC Curve ; Seroepidemiologic Studies ; Young Adult
مستخلص: Aim: To determine hepatitis C virus (HCV) seroprevalence and its genotypes, and to identify the factors associated with HCV infection.
Methods: This cross-sectional study, conducted in two prisons (one male and one female) in the State of Sergipe, Brazil, comprised 422 subjects. All of the prisoners underwent a rapid test for the detection of HCV antibodies. Patients with a positive result were tested for anti-HCV by enzyme linked immunosorbent assay and for HCV RNA by qualitative polymerase chain reaction (PCR). The virus genotype was defined in every serum sample that presented positive for PCR-HCV. In order to determine the factors independently associated with positive serology for HCV, multivariate logistic regression was used.
Results: HCV seroprevalence was 3.1%. Of the 13 subjects with positive anti-HCV, 11 had viremia confirmed by PCR. Of these, 90.9% had genotype 1. A total of 43 (10.2%) were injecting drug users, and HCV seroprevalence in this subgroup was 20.6%. The variable most strongly associated with positive serology for HCV was use of injecting drugs [odds ratio (OR), 23.3; 95% confidence interval (CI), 6.0-90.8]. Age over 30 years (OR, 5.5; 95%CI, 1.1-29.2), history of syphilis (OR, 9.8; 95%CI, 1.7-55.2) and history of household contact with HCV positive individual (OR, 14.1; 95%CI, 2.3-85.4) were also independently associated with HCV infection.
Conclusion: Most of the HCV transmissions result from parenteral exposure. However, there is evidence to suggest a role for sex and household contact with an infected subject in virus transmission.
References: J Infect Dev Ctries. 2010 Mar 29;4(3):144-9. (PMID: 20351454)
Rev Saude Publica. 2000 Oct;34(5):431-6. (PMID: 11105105)
Sex Transm Dis. 2000 Oct;27(9):491-5. (PMID: 11034522)
Hepatology. 2008 Nov;48(5):1387-95. (PMID: 18924228)
Am J Infect Control. 2007 Sep;35(7):477-80. (PMID: 17765561)
Clin Infect Dis. 2003 Aug 15;37(4):514-20. (PMID: 12905135)
Braz J Infect Dis. 2001 Jun;5(3):111-8. (PMID: 11506773)
Mem Inst Oswaldo Cruz. 2006 Sep;101(6):673-6. (PMID: 17072482)
East Mediterr Health J. 2007 Mar-Apr;13(2):250-6. (PMID: 17684845)
Clin Infect Dis. 2005 Aug 1;41(3):395-402. (PMID: 16007539)
World J Gastroenterol. 2005 Jul 14;11(26):4085-9. (PMID: 15996035)
J Epidemiol Community Health. 2008 Apr;62(4):305-13. (PMID: 18339822)
J Urban Health. 2004 Sep;81(3):448-52. (PMID: 15273267)
Braz J Infect Dis. 2006 Aug;10(4):274-8. (PMID: 17293911)
J Infect. 2006 Aug;53(2):125-30. (PMID: 16313963)
Eur J Epidemiol. 1999 May;15(5):439-45. (PMID: 10442469)
Euro Surveill. 2008 May 22;13(21):. (PMID: 18761967)
Prev Med. 2004 May;38(5):607-12. (PMID: 15066363)
Rev Soc Bras Med Trop. 2000 Jan-Feb;33(1):27-30. (PMID: 10881115)
AIDS. 2005 Oct;19 Suppl 3:S41-6. (PMID: 16251827)
Cad Saude Publica. 2007 Jan;23(1):197-205. (PMID: 17187118)
Rev Soc Bras Med Trop. 2009 Jul-Aug;42(4):369-72. (PMID: 19802469)
Rev Soc Bras Med Trop. 2008 May-Jun;41(3):238-42. (PMID: 18719801)
Clin Infect Dis. 2005 Jul 15;41(2):177-86. (PMID: 15983913)
Cad Saude Publica. 2006 Apr;22(4):839-48. (PMID: 16612437)
Int J Drug Policy. 2007 Oct;18(5):352-8. (PMID: 17854722)
Eur J Epidemiol. 2004;19(12):1119-22. (PMID: 15678792)
Epidemiol Infect. 2007 Feb;135(2):274-80. (PMID: 16824250)
Clin Chim Acta. 1999 Oct;288(1-2):91-6. (PMID: 10529461)
Rev Saude Publica. 2009 Aug;43 Suppl 1:43-50. (PMID: 19669064)
Lancet Infect Dis. 2009 Jan;9(1):57-66. (PMID: 19095196)
Am J Public Health. 2005 Mar;95(3):502-5. (PMID: 15727984)
J Med Microbiol. 2007 Mar;56(Pt 3):391-397. (PMID: 17314372)
Med J Aust. 2003 Jun 2;178(11):546-9. (PMID: 12765501)
Int J Med Sci. 2006;3(2):41-6. (PMID: 16614741)
Mem Inst Oswaldo Cruz. 2010 May;105(3):299-303. (PMID: 20512243)
BMC Infect Dis. 2008 Mar 07;8:33. (PMID: 18328097)
Braz J Med Biol Res. 2005 Jan;38(1):41-9. (PMID: 15665987)
Transfusion. 2005 Feb;45(2):133-40. (PMID: 15660820)
J Urban Health. 2004 Mar;81(1):25-37. (PMID: 15047781)
فهرسة مساهمة: Keywords: Brazil; Cross sectional analysis; Drug abusers; Hepatitis C; Prisoners
تواريخ الأحداث: Date Created: 20110730 Date Completed: 20111031 Latest Revision: 20211020
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC3132254
DOI: 10.3748/wjg.v17.i25.3027
PMID: 21799649
قاعدة البيانات: MEDLINE
الوصف
تدمد:2219-2840
DOI:10.3748/wjg.v17.i25.3027